
Leveraging advances in computation to revolutionize the design and development of therapeutic antibodies. DMs open. #AI #LifeScience #Antibodies #SciTech
- Tweets413
- Following1K
- Followers272
- Likes366

ALT Are you an antibody scientist feeling frustrated with the process of antibody discovery and engineering? You’re not alone. That’s why at EVQLV, we’re committed to transforming the field with our innovative AI-designed antibodies that can yield lab results in as little as 6 weeks. EVQLV’s technology generates diverse, fully-human antibodies that are screened for potential development failures. And now, for a limited time, you can try our AI-designed antibodies, with no royalties or milestones. Imagine the possibilities of what you could achieve with the power of AI on your side. Don’t miss out on this opportunity to experience the future of antibody discovery. Take 30 seconds to see if you qualify for our pilot program at https://evqlv.com/pilot2 Applications for our pilot close on May 1, 2023. Learn more from our AI-generated video at https://lnkd.in/eTgKgQ4s You can also see the results of some of our early de novo design work at https://evqlv.com/fob2

ALT If you’re a biotech professional who was affected by the massive 2022-23 layoffs, we deeply sympathize and want you to know that there is hope. Some of the greatest minds in history - Thomas Edison, Steve Jobs, Oprah Winfrey, and Walt Disney - faced adversity before achieving greatness. Have you considered this an opportunity to start your own biotech? At EVQLV, we believe that every challenge is an opportunity and we work every day to empowering scientists, like you, to create life-saving antibodies. You can begin your entrepreneurial journey today and design your own medicines by leveraging our cutting-edge AI-based antibody design. Kick off your own venture for FAR less than you imagined and be the master of your own destiny. Signup here before May at https://evqlv.com/pilot2 As Albert Einstein once said, “In the midst of every crisis, lies great opportunity.” Instead of starting your own biotech ‘one day,’ let’s make it ‘day one.’ Let’s create something incredible together.

